deltatrials
Unknown OBSERVATIONAL NCT00689364

Comprehensive Therapy to Relieving the Risk of Recurrence and Metastasis for Colorectal Cancer

Retrospective-Prospective Cohort Study Effectiveness of Comprehensive Therapy of TCM to Relieving the Risk of Recurrence and Metastasis for Stage II & III Colorectal Cancer Based on Conventional Western Medicine Therapy

Sponsor: Ministry of Science and Technology of the People´s Republic of China

Updated 6 times since 2017 Last updated: Jul 20, 2011 Started: Apr 30, 2007 Primary completion: Mar 31, 2012 Completion: Mar 31, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Colorectal Cancer and is currently ongoing. Ministry of Science and Technology of the People´s Republic of China leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Apr 2018 · 15 months · monthly snapshotUnknown Status~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 21 months · monthly snapshotUnknown

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown StatusUnknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status

  5. Apr 2018 — Jun 2018 [monthly]

    Unknown Status

    Phase: NANone

Show 1 earlier version
  1. Jan 2017 — Apr 2018 [monthly]

    Unknown Status NA

    First recorded

Apr 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ministry of Science and Technology of the People´s Republic of China
  • National Research Centre of Complementary and Alternative Medicine, Norway
Data source: Ministry of Science and Technology of the People´s Republic of China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations